# A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

> **NCT07215234** · PHASE1,PHASE2 · RECRUITING · sponsor: **Sanofi** · enrollment: 104 (estimated)

## Conditions studied

- Geographic Atrophy

## Interventions

- **DRUG:** SAR446597
- **DRUG:** Sham Comparator

## Key facts

- **NCT ID:** NCT07215234
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-09
- **Primary completion:** 2027-10-13
- **Final completion:** 2032-07-22
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07215234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07215234, "A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07215234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*